TX · AG Filing: Aug 18, 2026 · Recently disclosed — legal window is open
No cost. No obligation. If your data was exposed by Amgen Inc., you may be entitled to financial compensation.
Start Free Review →Based on the data types reported in this filing:
Your SSN is the master key to your identity. Once exposed, criminals can open new lines of credit, take out loans, or file taxes in your name.
Combined with a name and other leaked data, date of birth helps criminals pass identity verification questions at banks and government agencies.
Amgen Inc. was the subject of a data breach notification filed with the TX Attorney General. The AG filing was recorded on August 18, 2026. The breach or discovery date reported in the filing is July 1, 2026.
From the AG filing description
Amgen Inc. stands as one of the world's leading independent biotechnology companies, dedicated to discovering, developing, manufacturing, and delivering innovative human therapeutics to patients suffering from serious illnesses. Operating at the cutting edge of life sciences and pharmaceutical research, the organization manages extensive operations that require the collection, processing, and retention of massive quantities of highly sensitive information. This includes comprehensive clinical trial participant records, proprietary research data, employee personnel files, and deeply personal health information related to patients enrolled in specialized therapeutic support and distribution programs. Because of its pivotal role in the healthcare and biopharmaceutical sector, Amgen occupies a position of immense trust, holding data assets that are among the most sensitive and targeted in the corporate world. In 2026, Amgen Inc. reported a significant data security incident to the Office of the Texas Attorney General, triggering widespread concern among individuals whose personal and health-related information was entrusted to the company. While the exact vector of the compromise—whether stemming from sophisticated external cybercriminal operations, vulnerabilities within third-party vendor ecosystems, or unauthorized network access—continues to be scrutinized, incidents of this magnitude typically involve advanced persistent threats targeting legacy databases or cloud storage repositories. In the biotechnology and healthcare sectors, cybercriminals increasingly exploit complex digital supply chains and interconnected enterprise networks to bypass perimeter defenses, exfiltrating vast troves of confidential documents before detection occurs. The exposure resulting from the Amgen data breach encompasses a dangerous amalgamation of personally identifiable information and protected health data. Compromised records likely include full names, dates of birth, Social Security numbers, sensitive medical diagnosis and treatment histories, health insurance identification numbers, and clinical trial participation details. The exposure of this information carries severe, long-term risks for affected individuals. Unlike easily replaceable credit card numbers, foundational identifiers like Social Security numbers and detailed medical histories cannot be changed. When leaked, this data exposes victims to perpetual risks of targeted medical identity fraud—where unauthorized parties obtain healthcare services using another's name—as well as sophisticated phishing schemes, synthetic identity creation, and permanent financial exploitation. As a major entity operating within the healthcare and biotechnology sphere, Amgen Inc. was bound by stringent legal and regulatory frameworks, including the Health Insurance Portability and Accountability Act (HIPAA), the Texas Identity Theft Enforcement and Protection Act, and overarching state and federal common law duties of care. These legal mandates require covered entities and business associates to implement robust administrative, physical, and technical safeguards, such as end-to-end encryption, multi-factor authentication, regular vulnerability assessments, and strict access controls. The occurrence of a successful data breach of this scale strongly indicates potential failures in maintaining these mandatory security standards, raising serious questions regarding whether the company fulfilled its legal obligations to protect consumer and patient privacy. For individuals who have received an official data breach notification letter from Amgen Inc., that correspondence serves as formal legal acknowledgment that their private information was compromised due to corporate security shortcomings. Legally, the receipt of this letter establishes the foundational standing necessary to participate in a class action lawsuit aimed at demanding accountability, securing compensation, and forcing structural cybersecurity reforms. Crucially, affected individuals do not need to prove that they have already suffered actual financial loss or medical identity theft to seek legal redress; the increased, imminent risk of future harm is sufficient under modern jurisprudence. Our law firm is currently investigating potential class action claims on behalf of all impacted Texans, operating on a strict contingency fee basis—meaning you pay nothing out of pocket, and we only recover fees if we successfully secure a recovery on your behalf.
You may have been affected by the Amgen Inc. data breach if:
Common categories of compensation in data breach class actions
The hours spent responding to a data breach — canceling accounts, contacting credit bureaus, updating passwords, and investigating fraud — represent compensable economic harm in data breach litigation.
Once your SSN is exposed, protection becomes an ongoing expense. Plaintiffs in data breach settlements have recovered costs for credit freezes, identity protection subscriptions, and time spent dealing with fraudulent accounts — sometimes covering multiple years of exposure.
HIPAA violations carry civil penalties between $100 and $50,000 per violation. Where a healthcare organization's negligence led to the exposure of protected health information, class members may recover statutory damages in addition to actual losses.
Data breach victims regularly report anxiety, loss of sleep, and ongoing fear of identity theft. These non-economic harms are cognizable injuries in data breach litigation, particularly in cases involving SSN or medical record exposure.
Note: an attorney general breach filing does not by itself establish a settlement fund, a payment amount, or a claim deadline. If an official settlement notice is later issued, rely on that notice for payment details and deadlines.
Applicable State Law
This breach was reported under the Texas Identity Theft Enforcement and Protection Act, which mandates notification and establishes your right to seek damages.
No. Under Texas Identity Theft Enforcement and Protection Act and federal law, the unauthorized exposure of your personal data — regardless of whether it has been actively misused — can be sufficient grounds for a claim. The breach itself is the injury.
Nothing. The Law Office of David S. Harris handles data breach cases on contingency — you pay zero upfront and owe nothing unless compensation is recovered.
Immediately place a free credit freeze at all three bureaus (Equifax, Experian, TransUnion). A freeze blocks new accounts from being opened in your name. Then file a complaint with the FTC at IdentityTheft.gov and contact our office — SSN exposure is one of the most serious breach types.
If Amgen Inc. is a covered healthcare entity or business associate under HIPAA, affected patients have additional rights — including the right to an HHS complaint. These HIPAA violations also strengthen civil damages claims. Consult an attorney to understand your full remedies.
State statutes of limitations for data breach claims typically run 2–4 years from the date of the breach or its discovery. Because this breach was recently disclosed, the window is open — but acting early preserves your options and strengthens the case.
Accepting free credit monitoring from Amgen Inc. does not waive your right to pursue legal action unless you signed a specific release waiving claims. In most cases, victims who accepted monitoring can still file.
Not necessarily. Many data breach victims are never notified directly. If your personal information was held by Amgen Inc. during the relevant period, you may still qualify even without receiving a letter. A free eligibility review can confirm your status.
Learn how to participate in the class action and what compensation you may be entitled to.
Join the Class Action →Use our verification tool to confirm your letter matches this official AG filing.
Verify My Notice LetterThis case file references a public filing made with the state filing in TX. This website is not affiliated with, endorsed by, or operated by any state government agency.
Case review window ends October 13, 2026 — review your letter.
Review Your Letter →Amgen Inc. breach?
Free case review · No fee unless you win